Brain Tumor's Genetic Makeup Critical in Treatment, Research Finds

Doctors can more effectively treat many brain tumors by first ascertaining their genetic characteristics, rather than studying tissue samples under a microscope, which is the standard practice, two teams of researchers reported on June 10, 2015. CLICK HERE to read the entire New York Times article.

These studies provide a foundational rationale for ABC2's efforts in the profiling space. We have brought together a team of researchers from the Broad Institute, The Dana Farber Cancer Institute, Johns Hopkins, The Henry Ford Health Systems, Massachusetts General Hospital and The Mayo Clinic to develop a groundbreaking system that provides brain tumor patients and their physicians with rapid CLIA-compliant whole exome molecular tumor profiling. 

These profiles, provided free of charge, both guide patient care and create a uniquely powerful knowledgebase that will enable better treatments in the future. This new system is already providing profiles that form the front end of a unique vaccine clinical trial at Dana Farber Cancer Institute, and there are several more trials in the planning stages.

 

Main Image Credit: Dr. Daniel Brat of Emory University, lead author of one of the new studies, said genotyping would remove tumor variables. Photo by Donna Martin/Emory University.

 

Share |
August 13, 2022 05:05 PM
Brain Tumor Imaging Protocol will reduce variability in magnetic resonance imaging and increase accuracy in determining progression and response of investigational therapies
July 15, 2022 03:44 PM
Progress continues on the ABC2-funded immunotherapy research by Catherine Flores and her team at UF.
July 14, 2022 03:47 PM
Guest blogger Shawn Peters shares why he's running the 2015 Marine Corps Marathon to support ABC2.
Saturday, October 3, 2021
Sunday, May 1, 2022

Join us in our fight for a cure!

Twitter